BRILLIANCE trial

BRILLIANCE trial

Credit: OHSU News

Carlene Knight, who was born with a gene mutation that has caused her to be legally blind, looks up to the sky while sitting outside Oregon Health & Science Universitys Casey Eye Institute on April 29, 2021. As a participant in the BRILLIANCE clinical trial, Knight received an experimental gene-editing treatment that is designed to repair the mutation and improve eye sight. (OHSU/Josh Andersen)

Download Photo (17.0 MB)

Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X